Published on European Cystic Fibrosis Society (ECFS) (https://www.ecfs.eu)

Home > Chronic incretin-based therapy in cystic fibrosis-related diabetes: a tale of 3 patients treated with sitagliptin for over 5 years

Chronic incretin-based therapy in cystic fibrosis-related diabetes: a tale of 3 patients treated with sitagliptin for over 5 years

Resource Type

CF Research News

Authors

Samuel T Olatunbosun

References

J Cyst Fibros. 2021 Mar 2;S1569-1993(21)00040-0. doi: 10.1016/j.jcf.2021.02.005.

Document

PDF icon CF Research News Article [1]

Link

Scientific Abstract [2]

Keywords

Chronic incretin-based therapy [3]
Cystic-fibrosis related diabetes [4]
Dipeptidyl peptidase-4 inhibitor [5]
pancreatic insufficiency [6]
Sitagliptin [7]

Date

Tuesday, March 2, 2021

Featured resource article

Yes

Resource - Guideline Type

Other Guidelines [8]
Source URL:https://www.ecfs.eu/resource-article/cf-research-news/chronic-incretin-based-therapy-cystic-fibrosis-related-diabetes

Links
[1] https://www.ecfs.eu/sites/default/files/cf-research-article-files/JCF-D-20-00529R2_FINAL_Olatunbosun_070321.pdf [2] https://pubmed.ncbi.nlm.nih.gov/33674210/ [3] https://www.ecfs.eu/research-article-keywords/chronic-incretin-based-therapy [4] https://www.ecfs.eu/research-article-keywords/cystic-fibrosis-related-diabetes-1 [5] https://www.ecfs.eu/research-article-keywords/dipeptidyl-peptidase-4-inhibitor [6] https://www.ecfs.eu/research-article-keywords/pancreatic-insufficiency [7] https://www.ecfs.eu/research-article-keywords/sitagliptin [8] https://www.ecfs.eu/resource-guideline-type/other-guidelines